Claire GreenhillÂÂ
doi : 10.1038/s41574-022-00770-8
Volume 18 Issue 12, December 2022
Max Nieuwdorp & Hilde HerremaA
Samar A. Tolba & Vanessa A. LeoneA
Aoife M. Egan & Fidelma P. DunneA
Rahul Khatri & Thomas LinnA
Alina R. Murphy, Hannes Campo & J. Julie KimA
doi : 10.1038/s41574-022-00725-z
Each month during a woman’s reproductive years, the endometrium undergoes vast changes to prepare for a potential pregnancy. Diseases of the endometrium arise for numerous reasons, many of which remain unknown. These endometrial diseases, including endometriosis, adenomyosis, endometrial cancer and Asherman syndrome, affect many women, with an overall lack of efficient or permanent treatment solutions.
Wenxiang Hu & Mitchell A. LazarA
doi : 10.1038/s41574-022-00733-z
Metabolic diseases, including obesity, diabetes mellitus and cardiovascular disease, are a major threat to health in the modern world, but efforts to understand the underlying mechanisms and develop rational treatments are limited by the lack of appropriate human model systems.
Li Jiang, Kun Tang, Laura A. Magee, Peter von Dadelszen, Alec Ekeroma, Xuan Li, Enyao Zhang & Zulfiqar A. BhuttaA
doi : 10.1038/s41574-022-00734-y
Two important maternal cardiometabolic disorders (CMDs), hypertensive disorders in pregnancy (HDP) (including pre-eclampsia) and gestational diabetes mellitus (GDM), result in a large disease burden for pregnant individuals worldwide. A global consensus has not been reached about the diagnostic criteria for HDP and GDM, making it challenging to assess differences in their disease burden between countries and areas.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟